Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

melisana ag - ibuprofenum - dragees - ibuprofenum 400 mg, silica colloidalis anhydrica, maydis amylum, copovidonum, cellulosum microcristallinum, acidum alginicum, magnesii stearas, Überzug: saccharum 126.38 mg, talcum, carmellosum natricum, maydis amylum, povidonum k 25, cera carnauba, e 171, pro compresso obducto corresp. natrium 107 µg. - antiphlogistikum, antirheumatikum, analgetikum - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

melisana ag - ibuprofenum - dragees - ibuprofenum 600 mg, silica colloidalis anhydrica, maydis amylum, copovidonum, cellulosum microcristallinum, acidum alginicum, magnesii stearas, Überzug: saccharum 176.1 mg, talcum, carmellosum natricum, maydis amylum, povidonum k 25, cera carnauba, e 171, pro compresso obducto corresp. natrium 157 µg. - antiphlogistikum, antirheumatikum, analgetikum - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - torasemidum - tabletten - torasemidum 200 mg, lactosum monohydricum 97 mg, crospovidonum, povidonum, magnesium stearas, cellulosum microcristallinum, pro compresso. - diureticum - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - pantoprazolum - magensaftresistente tablette - pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 29.25 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum k 25, propylenglycolum, e 171, e 172 (flavum), acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, e 210 <0.65 µg, e 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 3.58 mg. - ulcustherapie, refluxoesophagitis, zollinger-ellison-syndrom - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - pantoprazolum - magensaftresistente tablette - pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 58.5 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum k 25, propylenglycolum, e 171, e 172, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, e 210 < 1.3 µg, e 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 7.17 mg. - ulcustherapie, refluxoesophagitis, zollinger-ellison-syndrom - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 40.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 6.75 mg. - protonenpumpenhemmer - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 20.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 3.38 mg. - protonenpumpenhemmer - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas et polysorbatum 80, triethylis citras, e 171, e 172 (flavum), drucktinte: lacca, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), ammoniae solutio concentrata pro compresso obducto corresp. natrium 3.38 mg. - protonenpumpenhemmer - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas et polysorbatum 80, triethylis citras, e 171, e 172 (flavum), drucktinte: lacca, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), ammoniae solutio concentrata pro compresso obducto corresp. natrium 6.75 mg. - protonenpumpenhemmer - synthetika

Švýcarsko - němčina - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - telmisartanum - tabletten - telmisartanum 40 mg, natrii hydroxidum corresp. natrium 1.931 mg, megluminum, povidonum k 25, lactosum monohydricum 37.2 mg, povidonum k 30, crospovidonum, lactosum 118.04 mg, magnesii stearas, pro compresso. - antihypertensivum - synthetika